STEVEN POPPER: Open Payments
NPI 1790302123 · MIDDLETOWN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$188 in 8 payments from 5 companies in 2025. Trend: 2023 $212 · 2024 $162 · 2025 $188
Food & beverage: $188
| Company | Payments | Amount |
|---|---|---|
| Adaptive Biotechnologies Corporation | 2 | $57 |
| Genentech USA, Inc. | 2 | $44 |
| Janssen Biotech, Inc. | 2 | $41 |
| GlaxoSmithKline, LLC. | 1 | $27 |
| SOBI, INC | 1 | $18 |
Products named: clonoSEQ, ERLEADA, JEMPERLI, Itovebi, Tecentriq Hybreza, Vonjo.
Industry payments across NJ — which companies pay providers there.
